The future is wireless, and CalAmp Corp, a prominent player in the Communication Equipment industry, is a stock to watch. With a total revenue of $186.2M and a forward PE of 0.9537, this NASDAQ-listed technology company offers a strategic investment opportunity. Despite a net income loss of $32.5M, the company's shares have a target price of $25.01, indicating potential for substantial growth. With the next press release poised to reveal more about CalAmp's future plans, now is the time to capitalize on this investment opportunity. Many millennials are steering clear of the communications equipment sector, making it worthwhile to delve deeper into CalAmp Corp and its current market trends. Despite the prevailing market uncertainty, we'll explore why this company may be undervalued by retail investors. Is CalAmp Corp's valuation justified? We'll examine the company's perspective on valuation to provide a clearer view for potential investors.
We determine the current worth of CAMP4 THERAPEUTICS PORATION using both absolute as well as relative valuation methodologies to arrive at its intrinsic value. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of CAMP4 THERAPEUTICS based exclusively on its
fundamental and basic
technical indicators. By analyzing CAMP4 THERAPEUTICS's
financials, quarterly and monthly indicators, and related drivers such as
dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of
CAMP4 THERAPEUTICS's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of CAMP4 THERAPEUTICS. We calculate exposure to CAMP4 THERAPEUTICS's
market risk, different
technical and
fundamental indicators, relevant financial multiples and ratios, and then
comparing them to CAMP4 THERAPEUTICS's related companies.
CAMP4 THERAPEUTICS Investment Alerts
CAMP4 investment alerts and warnings help investors to get more proficient at understanding not only critical technical and fundamental signals but also the significant portfolio-centered indicators. These indicators include beta, alpha, and other risk-related measures that will help you in monitoring CAMP4 THERAPEUTICS PORATION performance across your portfolios.Please check all
investment alerts for CAMP4
CAMP4 THERAPEUTICS Valuation Ratios as Compared to Competition
Our valuation model uses many indicators to compare CAMP4 value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CAMP4 THERAPEUTICS competition to find
correlations between indicators driving the intrinsic value of CAMP4.
CAMP4 THERAPEUTICS Gross Profit
CAMP4 THERAPEUTICS Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing CAMP4 THERAPEUTICS previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show CAMP4 THERAPEUTICS Gross Profit growth over the last 10 years. Please check CAMP4 THERAPEUTICS's
gross profit and other
fundamental indicators for more details.
Breaking it down
The latest spike in CalAmp Corp short term price appreciation could raise concerns from retail investors as the firm is trading at a share price of
3.63 on
11,218 in volume. The company directors and management have successfully maneuvered the firm at convenient times to take advantage of all market conditions in
April. The stock standard deviation of daily returns for 90 days investing horizon is currently 5.49. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the CalAmp Corp partners.
Margins Breakdown
CalAmp profit margins show the degree to which it makes money. Margin indicators are used not only by investors but also by creditors or CalAmp Corp itself as indicators of financial health and management effectiveness. Please look more closely at the different varieties of CalAmp Corp profit margins.
| Pretax Profit Margin | (0.47) |
| Operating Profit Margin | (0.0445) |
| Net Profit Margin | (0.48) |
| Gross Profit Margin | 0.25 |
CalAmp Corp Enterprise Value is decreasing over the last 5 years. The previous year's value of CalAmp Corp Enterprise Value was 7,119,471,418. CalAmp Corp Price To Sales Ratio is relatively stable at the moment.
Additionally, CalAmp Corp Market Cap is relatively stable at the moment. CalAmp Corp Enterprise Value is decreasing over the last 5 years. CalAmp Corp Price To Sales Ratio is decreasing over the last 8 years. Additionally, CalAmp Corp Market Cap is relatively stable at the moment. As Warren Buffet wisely said, be fearful when others are greedy and greedy when others are fearful. CalAmp Corp, a player in the Communication Equipment industry, presents a strategic investment opportunity. Despite a challenging operating margin of -0.12 and a net asset value of $380.12M, the company's current ratio stands at a healthy 1.86X, indicating a strong ability to cover its short-term liabilities. The firm's high beta of 1.97 suggests it's more volatile than the market, but this could mean greater potential for returns in a bullish market. However, investors should be mindful of the company's high probability of bankruptcy at 48.93%..
High level of complacency for CalAmp Corp after the latest price fall
CalAmp Corp's recent Risk Adjusted Performance has slightly improved to 0.06, but this should not be misconstrued as a sign of strong financial health. Despite a recent price drop, the market appears complacent towards the stock. Investors should be wary as the price may decline again due to underlying financial weaknesses. As of May 17, 2024, CalAmp Corp's Mean Deviation is 4.62, Risk Adjusted Performance is 0.0566, and Downside Deviation is 5.75. Technical analysis of CalAmp Corp uses historical prices and volume patterns to predict future price direction. However, it's uncertain if the firm will follow its historical price and volume momentum. We've gathered data for 19 technical drivers for CalAmp Corp for comparison with its peers.
Please verify CalAmp Corp's downside deviation, Jensen Alpha, and their relationship to determine if the stock is priced correctly at $3.63 per share. With a Jensen Alpha of 0.2324, it's advisable to assess CalAmp Corp's current market performance to ensure its future sustainability.In conclusion, CalAmp Corp (CAMP) presents a mixed bag for investors. With an analyst overall consensus of a 'Hold', the company has an equal number of 'Buy' and 'Sell' recommendations, at
1 each. The analyst target price estimated value stands at
1.77, with the highest and lowest estimated target prices being 1.96 and 1.61 respectively. This suggests a potential downside risk of 0.0363, but also a possible upside price of 9.08. The valuation real value is currently lower than both the valuation hype value of 3.66 and the market value of 3.63, indicating a possible undervaluation. However, with the naive expected forecast value at 3.59, it is uncertain whether CalAmp Corp will recuperate in June. Investors should carefully consider these factors before making a decision..
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Vlad Skutelnik is a Macroaxis Contributor. Vlad covers stocks, funds, cryptocurrencies, and ETFs that are traded in North America, focusing primarily on fundamentals, valuation and market volatility. He has many years of experience in fintech, predictive investment analytics, and risk management.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of CAMP4 THERAPEUTICS PORATION. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
[email protected]